Carbidopa/levodopa/entacapone Levodopa-induced dyskinesia Carbidopa/levodopa Levodopa/benserazide Levodopa Entacapone Catechol-O-methyltransferase inhibitor Carbidopa Melevodopa/carbidopa Melevodopa XP-21279 Benserazide Management of Parkinson's disease Tolcapone Monoamine precursor L-DOPA Foscarbidopa/foslevodopa Dihydroergocryptine Besonprodil Etilevodopa Opicapone Foslevodopa DopAmide Parkinson's disease Aromatic L-amino acid decarboxylase inhibitor Dyskinesia Dipraglurant Befiradol Dopamine dysregulation syndrome Glovadalen Mesdopetam Medial forebrain bundle D-DOPA Etybenzatropine Pallidotomy Safinamide Foscarbidopa Brasofensine Ap…

praxia of lid opening Acorda Therapeutics Thalamotomy Prolactin modulator Droxidopa Peripherally selective drug Nebicapone Sepiapterin reductase deficiency Catechol-O-methyltransferase Mavoglurant Neluxicapone Istradefylline Fregoli delusion History of Parkinson's disease Remacemide O,O′-Diacetyldopamine MPTP Lisuride Neurolixis Gene therapy in Parkinson's disease Dopamantine BTS 74,398 Highlands Hospital 6-Hydroxydopa Cabergoline Manganism Punding Amantadine Ariadne (drug) 4-Methylphenylisobutylamine Arbutin 4-Fluoroamphetamine Akinetic mutism Parkinson's

Foundation 4-Methylpentedrone Plasma membrane monoamine transporter 4-Methylaminorex Armesocarb Norsalsolinol Zonisamide Dietary management of Parkinson's disease 4-Bromomethcathinone 4-Methylethcathinone 4-Methylamphetamine 4-Methylthioamphetamine 4-Ethylmethcathinone Neurotransmitter prodrug Dopamine agonist 3-O-Methyldopa Parkinsonian gait Régis Bordet Lataisia Jones 4-Fluoromethamphetamine Dopaminergic A-86929 MPP+ 4-Methyl-α-methyltryptamine 4'-Fluoro-α-pyrrolidinooctanophenone Sarizotan 4-Fluoroselegiline 4-Fluoroethcathinone 4-Methyl-α-ethylaminopentiophenone 4-Methylbuphedrone 4-Met